• FDA approves first blood test to detect amyloid plaques linked to Alzheimer’s
    Dementia11 Jun

    The US Food and Drug Administration (FDA) has cleared the first blood test capable of detecting amyloid plaques, one of the key signs of Alzheimer’s disease, offering a simpler alternative to current diagnostic methods. The test, which received FDA clearance on 16 May, is approved for people aged 55 and over who show signs or [...]

  • Research roundup: improving stroke treatment, gene variant doubles dementia risk for men, and more
    Stroke9 Jun

    NR Times explores the latest research developments impacting on neuro-rehab. Newly developed technique may improve success rates in treating strokes Researchers at Stanford Engineering have developed a new technique called the milli-spinner thrombectomy that could significantly improve success rates in treating strokes. The treatment may also improve success rates for treating heart attacks, pulmonary embolisms, [...]

  • FDA approves study of test for predicting risk of Alzheimer’s Disease
    Dementia30 May

    Brain health technology company Darmiyan has announced that the U.S. Food and Drug Administration (FDA) has approved the company's post-market surveillance study for BrainSee, its clinical prognostic tool for Alzheimer's disease. The seven-year study aims to further validate the safety and effectiveness of BrainSee in a socio-demographically diverse patient population across the United States. The [...]

  • Sleep aid blocks neurodegeneration in mice
    Dementia29 May

    A common sleep aid restores healthier sleep patterns and protects mice from the brain damage seen in neurodegenerative disorders, such as Alzheimer’s disease, according to new research.  The drug, lemborexant, prevents the harmful buildup of an abnormal form of a protein called tau in the brain, reducing the inflammatory brain damage tau is known to [...]

  • Ex-Service personnel with dementia may be slipping through gaps in support
    Dementia23 May

    New research has highlighted the experiences of UK ex-Service personnel with dementia who are living in their own homes, and the barriers they have faced in accessing support. The research, funded by Forces in Mind Trust and carried out by the University of Manchester and McMaster University, was the first qualitative study with ex-Service personnel living [...]

  • Cold sore viral infection implicated in development of Alzheimer’s disease
    Brain injury22 May

    Symptomatic infection with the virus responsible for cold sores around the mouth–herpes simplex 1, or HSV-1 for short - may have a key role in the development of Alzheimer’s disease, suggests a new study. But treatment with antiviral therapy seems to be linked to a lower risk of this type of dementia, suggesting that treatment to [...]

  • “Spoonful” of microplastics in human brains could link to depression and dementia
    Dementia20 May

    A groundbreaking collection of four papers has synthesised mounting evidence that microplastics from ultra-processed foods may be accumulating in human brains - and it may potentially be contributing to the rising global rates of depression, dementia, and other mental health disorders. The papers provide the most comprehensive analysis to date of how these tiny plastic [...]

  • Potential new targets for Alzheimer’s drugs discovered
    Dementia20 May

    By combining information from many large datasets, researchers have identified several new potential targets for treating or preventing Alzheimer’s disease. The study revealed genes and cellular pathways that haven’t been linked to Alzheimer’s before, including one involved in DNA repair. Identifying new drug targets is critical because many of the Alzheimer’s drugs that have been [...]

  • Low-cost blood test for early Alzheimer’s detection developed
    Dementia19 May

    Researchers have developed a blood test that can identify early signs of Alzheimer’s disease by measuring proteins linked to the condition. The new test, known as Penta-Plex Alzheimer’s Disease Capture Sandwich Immunoassay (5ADCSI), detects five biomarkers simultaneously, which is more than existing blood tests and runs on equipment commonly used in many laboratories. Scientists have [...]

  • Sedentary behaviour is an independent risk factor for Alzheimer’s disease
    Dementia14 May

    Over six million Americans are impacted by Alzheimer’s disease, and researchers are discovering how lifestyle habits can impact the likelihood of developing the disease. According to a new research, increased sedentary behaviour, such as time spent sitting or lying down, in ageing adults was associated with worse cognition and brain shrinkage in areas related to [...]